Open access · OA
via OpenAlex
Intervention Study Comparing Blood NAD+ Concentrations with Liposomal and Non-Liposomal Nicotinamide Mononucleotide
Satoshi Kawakami, Yusuke Maeda, Yoshitaka Fukuzawa
Annals of Clinical and Medical Case Reports · 2025
Abstract
It is now known that lifestyle-related diseases are caused by senescence(definition). The International Classification of Diseases, 11th Edition (ICD-11) has coded the item "related to aging," and aging has come to be considered a disease. Therefore, mitochondrial activity is currently attracting attention as a way to prevent aging. Our research team screened various substances and found that nicotinamide mononucleotide (NMN) is effective in mitochondrial activity. However, there are many NMN products on the market, and issues remain regarding their content and unconfirmed effectiveness. Therefore, in this exploratory clinical study, liposomal NMN, non-liposomal NMN for 4 weeks, 350 mg/day of NMN, and a placebo were administered in a double-blind manner, and the levels of nicotinamide adenine dinucleotide (NAD+) were measured. As a result, the expression level of NAD+ was significantly higher in liposomal NMN, and we will report on its effects and underlying mechanism.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.47829/acmcr.2025.141102
- Canonical
- link ↗
- Fetched
- 2026-10-09 MST
Cite this
APA
Kawakami, S., Maeda, Y., & Fukuzawa, Y. (2025). Intervention Study Comparing Blood NAD+ Concentrations with Liposomal and Non-Liposomal Nicotinamide Mononucleotide. <em>Annals of Clinical and Medical Case Reports</em>. https://doi.org/10.47829/acmcr.2025.141102
Vancouver
Kawakami S, Maeda Y, Fukuzawa Y. Intervention Study Comparing Blood NAD+ Concentrations with Liposomal and Non-Liposomal Nicotinamide Mononucleotide. Annals of Clinical and Medical Case Reports. 2025. doi:10.47829/acmcr.2025.141102.
BibTeX
@article{satoshi2025Interv,
title = {Intervention Study Comparing Blood NAD+ Concentrations with Liposomal and Non-Liposomal Nicotinamide Mononucleotide},
author = {Satoshi Kawakami and Yusuke Maeda and Yoshitaka Fukuzawa},
journal = {Annals of Clinical and Medical Case Reports},
year = {2025},
doi = {10.47829/acmcr.2025.141102},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Advance Research in Medical & Health Science 2024
Open access · CC-BY
EFFICACY OF NICOTINAMIDE MONONUCLEOTIDE SUPPLEMENTATION (NMN) IN BLOOD NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD) FOR ANTI-AGING IN ADULTS: A SYSTEMATIC REVIEW
npj Metabolic Health and Disease 2025
Open access · CC-BY
The role of NAD+ metabolism and its modulation of mitochondria in aging and disease
Aging Medicine 2021
Open access · CC-BY
Precursor comparisons for the upregulation of nicotinamide adenine dinucleotide. Novel approaches for better aging
Drug Design Development and Therapy 2026
Open access · CC-BY
Restorin® NR is a Highly Efficient NAD+ Precursor
Drug design, development and therapy 2026
Open access · OA
Restorin<sup>®</sup> NR is a Highly Efficient NAD<sup>+</sup> Precursor.
Current Nutrition Reports 2023
Open access · OA